← Back to Patent Explorer
EP0088903A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

1,4-Dihydropyridine-3,5-dicarboxylic acid ester derivatives

Assignee: Tanabe Pharma Corp
•
Filing: 1983-02-17
•
Granted: —
•
Expires: 2003-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1,4-Dihydropyridine-3,5-dicarboxylic acid ester derivatives of the general formula: or acid addition salts thereof, wherein W is -CH= or -N=; Y is -CH= CH -, -0-, -S-, -CH=N(O)p- (p is zero or 1) or -N(R)- (R is hydrogen or lower alkyl); X 1 , X 2 and X 3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkylthio; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent or two or three substituents which may be the same or different, and the substituent may be halogen, lower alkyl, lower alkoxy, lower alkanoylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkylsulfamoyl, amino or di-lower alkylamino); -N A is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, sulfur atom or unsaturated bond on the ring, and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or ―(CH 2 ) m ―OR 4 (R 4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2); R' and R 2 are the same or different, and are eaah lower alkyl; R 3 is lower alkyl, aralkyl, heteroaralkyl; and n is an integer 1 to 5. Such compounds are useful as antihypertensive agents and as therapeutic agents for cardiac and cerebral circulation disorders.

Inventors

  • 👤 Kazuhiko Araki
  • 👤 Hideki Ao
  • 👤 Jun Inui
  • 👤 Ken-Ichi Aihara

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-25 06:17
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/89; C07D211/00; C07D211/04; C07D211/80; C07D211/84; C07D211/90; C07D401/00; C07D401/02; C07D401/04; C07D401/12; C07D405/00; C07D405/02; C07D405/04; C07D405/12; C07D407/00; C07D407/02; C07D407/12; C07D409/00; C07D409/02; C07D409/04; C07D409/12; C07D409/14; C07D413/00; C07D413/02; C07D413/12; C07D417/00; C07D417/02; C07D417/04; C07D417/12; C07D491/00; C07D491/02; C07D491/10

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 221 words
A 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative of the general formula: or a pharmaceutically acceptable acid addition salt thereof, wherein W is -CH= or -N=; Y is -CH=CH-, -O-, -S-, -CH=H(O)p- (p is zero or 1) or -N(R)- (R is hydrogen or lower alkyl); X 1 , X 2 and X 3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkyl; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent aromatic heterocyclic ring (which may have a substituent or two or three substituents which are the same or different, and the substituent may be halogen, lower alkyl lower alkoxy, lower alkancylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkylsulfamoyl, amino or di-lower alkylamino); is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, sulfur atom or unsaturated bond on the ring oxygen atom, sulfur atom or unsaturated bond on the ring and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or -(CH 2 ) m -OR 4 (R 4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2) R 1 and R 2 are the same or different and are each lower alkyl; R 3 is lower alkyl, aralkyl or heteroaralkyl; and n is an integer 1 to 5.
Claim 2
Dependent Claim 221 words
A 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative of the general formula: or a pharmaceutically acceptable acid addition salt thereof, wherein W is -CH= or -N=; Y is -CH=CH-, -O-, -S-, -CH=H(O)p- (p is zero or 1) or -N(R)- (R is hydrogen or lower alkyl); X 1 , X 2 and X 3 are the same or different, and are each hydrogen, halogen, nitro, trifluoromethyl, cyano or lower alkyl; Z is aryl or 5- or 6-membered aromatic heterocyclic ring (which may have a substituent aromatic heterocyclic ring (which may have a substituent or two or three substituents which are the same or different, and the substituent may be halogen, lower alkyl lower alkoxy, lower alkancylamino, cyano, nitro, lower alkylthio, trifluoromethyl, sulfamoyl, di-lower alkylsulfamoyl, amino or di-lower alkylamino); is 5- to 7-membered heterocyclic ring which may have nitrogen atom, oxygen atom, sulfur atom or unsaturated bond on the ring oxygen atom, sulfur atom or unsaturated bond on the ring and may be substituted by lower alkyl, lower alkoxycarbonyl, lower alkanoylamino, ethylenedioxy or -(CH 2 ) m -OR 4 (R 4 is hydrogen, lower alkyl or lower alkanoyl and m is 0, 1 or 2) R 1 and R 2 are the same or different and are each lower alkyl; R 3 is lower alkyl, aralkyl or heteroaralkyl; and n is an integer 1 to 5.
Claim 3
Dependent Claim 7 words
The-compound of Claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3- methylester-5-(1-phenyl-2-piperidinoethyl)ester.
Claim 4
Dependent Claim 7 words
The compound of Claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-[1-(2-thienyl)-2-piperidinoethyl]ester.
Claim 5
Dependent Claim 7 words
The compound of Claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-[1-(2-furyl)-2-piperidinoethyl]ester.
Claim 6
Dependent Claim 8 words
The conpound of Claim 1: 2,6-dimethyl-4-(2-thienyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5- (1-phenyl-2-piperidinoethyl)ester.
Claim 7
Dependent Claim 8 words
The conpound of Claim 1: 2,6-dimethyl-4-(2-furyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5- (1-phenyl-2-piperidinoethyl)ester.
Claim 8
Dependent Claim 9 words
The compound of Claim 1: 2,6-dimethyl-4-(2-furyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5- [2-piperidine-1-(2-thienyl)ethyl] ester.
Claim 9
Dependent Claim 7 words
The compound of Claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-(2-morpholino-1-phenylethyl)ester.
Claim 10
Dependent Claim 7 words
The conpound of Claim 1: 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methylester-5-[1-phenyl-2-(1-pyrrolidinyl)ethyl]ester.
Claim 11
Dependent Claim 26 words
A pharmaceutical composition comprising the compound of Claim 1 in combination with a pharmaceutically acceptable inert carrier, said compound being present in a therapeutically effective amount.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag